In the future, such a study should be conducted, but for now, we have shown the potential efficiency of the analysis of the holo-Tf and apo-Tf ratio using monoclonal nanoantibodies for the identification of women with ovarian cancer. The gene discussed is TF; the disease is ovarian carcinoma.